Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicortex International

1.30 SEK+5.28 %3/9 16:36
Less than 1K followers

MEDFIN B

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+5.28 %
-8.80 %
-52.04 %
-44.89 %
-60.28 %
-67.63 %
-96.31 %
-98.94 %
-99.20 %

Medicortex International is a medical technology company that develops diagnostic solutions for traumatic brain injuries, with a focus on biomarker-based tests. The company conducts research and development with the goal of enabling rapid and accessible diagnostics and works long-term with the development of treatment solutions. The business has an international focus.

Read more
Market cap
30.22M SEK
Turnover
8.37K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-09-01 13:48

Medicortex International AB (publ) ingår avtal inför riktade kvittningsemissioner om totalt cirka 9,9 MSEK

Medicortex International
Regulatory press release2026-09-01 13:48

Medicortex International AB (publ) enters into agreements ahead of planned directed set-off share issues totalling approximately SEK 9.9 million

Medicortex International
Regulatory press release2026-08-31 16:37

Medicortex International AB (publ) publishes interim report for the period April–June 2026

Medicortex International

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-08-31 16:37

Medicortex International AB (publ) offentliggör delårsrapport för perioden april–juni 2026

Medicortex International
Regulatory press release2026-08-28 17:00

Medicortex International AB (publ): Delårsrapporten för andra kvartalet 2026 publiceras den 31 augusti 2026

Medicortex International
Regulatory press release2026-08-28 16:58

Medicortex International AB (publ): Interim Report for the Second Quarter of 2026 to be Published on 31 August 2026

Medicortex International
Regulatory press release2026-08-20 13:10

A New Chapter for Medicortex International – From Scientific Innovation to Commercial Execution

Medicortex International
Press release2026-08-11 09:00

Shareholder Update – August 2026

Medicortex International
Regulatory press release2026-07-06 09:05

CEO Letter: Leading the Future of Brain Injury Diagnostics

Medicortex International
Regulatory press release2026-06-30 18:10

Medicortex International: förvärvet slutfört, NGM-villkor uppfyllda, Adrian Harel ny VD

Medicortex International
Regulatory press release2026-06-30 14:04

Kommuniké från årsstämma i Medicortex International AB (publ) den 30 juni 2026

Medicortex International
Regulatory press release2026-06-30 11:38

NOSIUM byter namn till Medicortex International AB (publ) – registrerat hos Bolagsverket

Medicortex International
Regulatory press release2026-06-18 12:05

NOSIUM AB (publ)har erhållit villkorat godkännande för fortsatt notering på NGM Growth Market

Medicortex International
Regulatory press release2026-06-05 16:30

RÄTTELSE: NOSIUM AB (publ) publicerar komplett årsredovisning för 2025 inklusive revisionsberättelse

Medicortex International
Regulatory press release2026-06-05 14:00

NOSIUM AB (publ) publicerar årsredovisning för 2025 och uppdaterar kring processen med Medicortex

Medicortex International
Regulatory press release2026-06-02 08:30

KALLELSE TILL ÅRSSTÄMMA I NOSIUM AB (PUBL)

Medicortex International
Regulatory press release2026-05-28 15:00

NOSIUM AB (publ) offentliggör delårsrapport för perioden januari–mars för 2026

Medicortex International
Regulatory press release2026-05-28 14:50

NOSIUM AB (publ) informerar om nedskrivning av Dr Sannas Sweden AB och uppdaterar tidplan för årsredovisning

Medicortex International
Regulatory press release2026-05-27 11:12

NOSIUM UPPMÄRKSAMMAR: BREV FRÅN MEDICORTEX STYRELSEORDFÖRANDE TILL AKTIEÄGARNA

Medicortex International
Regulatory press release2026-05-22 09:21

NOSIUM UPPMÄRKSAMMAR: MEDICORTEX FÅR FÖRLÄNGNING AV DoD-PROJEKT

Medicortex International